Clinical Trial

The Effectiveness of Acceptance and Commitment Therapy (ACT) on Dysfunctional Attitudes and Difficulties in Emotion Regulation Among University Students in Malaysia

Completed
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to learn if Acceptance and Commitment Therapy (ACT) can reduce dysfunctional attitudes and difficulties in emotion regulation among university students in Malaysia.The main questions it aims to answer are: * Will participants who receive ACT show statistically significant reduction in dysfunctional attitudes scores compared to those in the control group? * Will participants who receive ACT show statistically significant reduction in difficulties in emotion regulation scores compared to those in the control group? * Will participants who receive ACT show statistically significant reduction in dysfunctional attitudes scores from pre-test to intermediate-test and from pre-test to post-test? * Will participants who receive ACT show statistically significant reduction in difficulties in emotion regulation scores from pre-test to intermediate test and from pre-test to post-test? Researchers will compare ACT group to a waitlist control group to see if ACT work to reduce dysfunctional attitudes and difficulties in emotion regulation. Participants in the ACT group will * attend six weekly individual sessions of ACT intervention (1 hour per session) conducted online * complete the outcome measures at three different time points (week 1, week 3, and week 6) Meanwhile, participants in the waitlist control group * will not receive any intervention during the data collection period * will be asked to complete same outcome measures at three different time points (week 1, week 3, and week 6)
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-19.
Trial Details
NCT Number NCT07256093
Lead Sponsor Universiti Sains Malaysia
Conditions Anxiety, Depression, Stress
Enrollment 32 participants
Start Date 2025-02-10
Primary Completion 2025-03-20 (estimated)
Study Completion 2025-04-25 (estimated)
Updated on ClinicalTrials.gov 2026-04-30